nach oben

memo - Magazine of European Medical Oncology

Erschienen in:

01.06.2023 | editorial

Colorectal cancer special, part 2

verfasst von: Prof. Dr. Armin Gerger

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 2/2023

Einloggen, um Zugang zu erhalten

Excerpt

In this special issue of the Magazine of European Medical Oncology (MEMO) multidisciplinary experts summarize and discuss recent developments and future perspectives of treatment of colorectal cancer spanning from local therapies to molecular pathology and systemic treatment [1, 2]. …

Vorheriger Artikel ESMO 2022

Nächster Artikel Selection of phase II/III breast cancer study highlights at the 2022 ESMO annual meeting

Langer R, Noack P. Molecular pathology of colorectal cancer. memo. 2023. https://doi.org/10.1007/s12254-022-00854-1.CrossRef

Schmalfuss T, Taghizadeh H. Lessons learnt in adjuvant colorectal cancer. memo. 2023;16(2).

Titel: Colorectal cancer special, part 2
verfasst von: Prof. Dr. Armin Gerger
Publikationsdatum: 01.06.2023
Verlag: Springer Vienna
Erschienen in: memo - Magazine of European Medical Oncology / Ausgabe 2/2023
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI: https://doi.org/10.1007/s12254-023-00890-5

Springer Medizin Österreich

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2023

Lessons learned in adjuvant colorectal cancer

Neoadjuvant and adjuvant therapy in early breast cancer. A short review on current clinical approaches

Spectrum of renal involvement in MGRS patients: a 6-year study

Molecular pathology of colorectal cancer

Excellent response of a disseminated SMARCA4-deficient thoracic sarcomatoid tumor to immunochemotherapy—a case report

Selection of phase II/III breast cancer study highlights at the 2022 ESMO annual meeting